Search filters
Filters
Clear All

Phase

  • 59
  • 97
  • 108
  • 90
  • 14
  • 168
  • 694
  • 444
  • 14
  • 31
  • 1
  • 4
  • 646

Found 696 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

An Open-Label Multicenter Follow-up Trial of ARGX-113-1904 to Evaluate the Safety Tolerability and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus ARGX-113-1905

99 years or below
All genders
Phase 3
4.0
Learn More

UPCC 04121 A Phase 1b/2 Study of the PARP Inhibitor Niraparib in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer

99 years or below
All genders
Phase 1
0.0
Learn More

Prevalence of Gastric and Duodenal Neoplasia in Patients with Colon Polyposis of Unknown Etiology: a Multi-Center Analysis

99 years or below
All genders
TBD
Learn More

A Phase 3 Prospective Multi-Center Single-Arm Open-Label Study to Evaluate LevoCept a Long-Acting Reversible Intrauterine System for Contraceptive Efficacy Safety and Tolerability

99 years or below
All genders
TBD
Learn More

Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety Tolerability and Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

99 years or below
All genders
TBD
Learn More

UPCC 54419: A Phase II Open-label Multicenter Study to Assess the Efficacy and Safety of AFM13 in Patients with Relapsed or Refractory CD30-positive Peripheral T-cell Lymphoma or Transformed Mycosis Fungoides (REDIRECT)

99 years or below
All genders
This study enrolls subjects with relapsed or refractory CD30-positive Peripheral T-cell Lymphoma (PTCL) or Transformed Mycosis Fungoides (TMF). The purpose of this study is to learn about the effects of a research medicine called AFM13 and to see how well AFM13 is tolerated. This study is divided in three cohorts, …
Learn More

Test SSO Now 5 PI123

C
Chace Brokaw Chace Brokaw
99 years or below
Female
Phase 1
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol  PI123
Learn More

403 trial 3

E
EDWARD STADTMAUER
99 years or below
All genders
See protocol section 2 See protocol section 2 See protocol section 2
Learn More
A Randomized, Multicenter Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension, “Ambition” Trial

A Randomized, Multicenter Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension, “Ambition” Trial

18 years - 75 years
All genders
Phase 3
Interventional
This clinical research study involves an experimental combination of two drugs, ambrisentan and tadalafil for the treatment of Pulmonary Arterial Hypertension (a narrowing of the arteries connecting the lungs to the heart that leads to an increase in blood pressure). This is also known as PAH. These drugs have been …
Learn More
A randomized, open-label, comparative study for Edoxaban and Enoxaparin/Warfarin vs Warfarin alone in subjects with Atrial Fibrillation who have undergone Electrical Cardioversion

A randomized, open-label, comparative study for Edoxaban and Enoxaparin/Warfarin vs Warfarin alone in subjects with Atrial Fibrillation who have undergone Electrical Cardioversion

1 years - 99 years
All genders
Phase 3
The purpose of this study is to compare edoxaban with warfarin to see if it is safe and effective in preventing thromboembolism (formation of a clot [thrombus] in a blood vessel that breaks loose and is carried by the blood stream to block another vessel) and strokes which results when …
Learn More
351 - 360 of 696